Holding(s) in Company

15 Dec 2006 16:39

ReGen Therapeutics PLC15 December 2006 London, UK - 15 December, 2006: ReGen Therapeutics Plc (the "Company") announcesthat today it received notification from Mr Tigran Kalaydjian that he isbeneficially interested in 21,000,000 ordinary shares of the Companyrepresenting 3.03% of the current issued share capital of the Company. For further information, please contact: Andrew Marshall Tel. 020 7960 6007Greycoat Communications This information is provided by RNS The company news service from the London Stock Exchange